CORZ
The table below shows Core Scientific, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q3 2022 | Q1 2022 |
|---|---|---|---|---|---|---|
| Operating cash flow | $249.88M | -$45.04M | $22.17M | $19.94M | -$52.10M | -$3.62M |
| Capital expenditure | $389.23M | $83.98M | $31.89M | $1.54M | $5.20M | $133.22M |
| Investing cash flow | -$386.65M | -$89.02M | -$31.97M | -$1.87M | -$5.70M | -$269.10M |
| Dividends paid | - | - | - |
Core Scientific, Inc. reported operating cash flow of $278.25M for fiscal year 2025. That is up 548.7% from $42.90M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from -$23.77M (FY 2020) to $278.25M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $971.38M | -$4.20M | $54.36M | -$1.02M | -$45.10M | $251.47M |